Gilead stock edged lower late Thursday after the biotech company reported adjusted earnings of $1.87 per share on $6.217 billion in second-quarter sales.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,